Menu
About
Benefits
Email
News
Education
Careers
Forum
App
Work with us
Careers at M3
Marketing Solutions
Recruitment Solutions
Log in
Join
Contact
Log in
Join
Contact
Individualised mRNA vaccine for melanoma trialled in UK patients
26 April 2024
0
comments
Dr Heather Shaw with patient Steve Young. Credit: Yui Mok/PA Wire
By Jane Kirby, PA Media
The world’s first personalised individualised neoantigen therapy (INT) for melanoma – which also has the potential to stop lung, bladder and kidney cancer – is being tested in British patients in a phase 3 trial.
Log in
or
join
to read more
You might also like